Literature DB >> 7216242

Enhancement of human amniotic cell growth by Ficoll-Paque gradient fractionation.

H C Chang, O W Jones, C Bradshaw, S Sarkar, R P Porreco.   

Abstract

Ficoll-Paque isopycnic centrifugation was used as a preparative procedure for amniotic fluid (AF) cells prior to tissue culture. This technique serves to reduce contaminating erythrocytes and also enhances cell growth or mitotic indices. The technique described in this report yields three subfractions designated as a turbid interphase layer (F-2), a middle cell layer (F-3), and a bottom pellet (F-4). The middle cell layer (F-3) demonstrated better cell growth and higher mitotic index than any of the other fractions or control unfractionated amniotic fluid cells. The use of Ficoll-Paque isopycnic preparative centrifugation of amniotic fluid cells is a valuable adjunct in cell culture for cytogenetic analysis. This may be especially true when amniotic fluid contains large numbers of erythrocytes.

Entities:  

Mesh:

Year:  1981        PMID: 7216242     DOI: 10.1007/bf02618035

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  25 in total

1.  Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II. Cytogenetic parameters as functions of clonal type and preparative technique.

Authors:  H Hoehn; E M Bryant; L E Karp; G M Martin
Journal:  Clin Genet       Date:  1975-01       Impact factor: 4.438

2.  A METHOD FOR DIRECT DEMONSTRATION OF PLEUROPNEUMONIA-LIKE ORGANISMS IN CULTURED CELLS.

Authors:  J FOGH; H FOGH
Journal:  Proc Soc Exp Biol Med       Date:  1964-12

3.  Differentiation in human amniotic fluid cell cultures: chorionic gonadotropin production.

Authors:  R E Priest; J H Priest; J F Moinuddin; D S Sgoutas
Journal:  In Vitro       Date:  1979-02

4.  Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential.

Authors:  H Hoehn; E M Bryant; L E Karp; G M Martin
Journal:  Pediatr Res       Date:  1974-08       Impact factor: 3.756

5.  Cultivated epithelial-like cells and fibroblasts from amniotic fluid: their relationship to enzymatic and cytologic analysis.

Authors:  A B Gerbie; S B Melancon; C Ryan; H L Nadler
Journal:  Am J Obstet Gynecol       Date:  1972-10-01       Impact factor: 8.661

6.  Possibility of culturing foetal cells at early stages of pregnancy.

Authors:  N Hahnemann
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

Review 7.  European experience with prenatal diagnosis of congenital disease: a survey of 6121 cases.

Authors:  H Galjaard
Journal:  Cytogenet Cell Genet       Date:  1976

8.  Lysosomal enzyme activities in different types of amniotic fluid cells measured by microchemical methods, combined with interference microscopy.

Authors:  E Van der Veer; W J Kleijer; J E de Josselin de Jong; H Galjaard
Journal:  Hum Genet       Date:  1978-02-16       Impact factor: 4.132

9.  Neural origin of cells in amniotic fluid.

Authors:  S Sarkar; H C Chang; R P Porreco; O W Jones
Journal:  Am J Obstet Gynecol       Date:  1980-01-01       Impact factor: 8.661

10.  Morphology of rapidly adhering amniotic-fluid cells as an aid to the diagnosis of neural-tube defects.

Authors:  C M Gosden; D J Brock
Journal:  Lancet       Date:  1977-04-30       Impact factor: 79.321

View more
  3 in total

1.  Human amniotic fluid cells grown in a hormone-supplemented medium: suitability for prenatal diagnosis.

Authors:  H C Chang; O W Jones; H Masui
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

2.  Isolation of large numbers of dispersed human pituitary adenoma cells obtained by aspiration.

Authors:  R Oosterom; G Blaauw; R Singh; T Verleun; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

3.  PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells.

Authors:  Shuiling Jin; Yanfang Mi; Jing Song; Peipei Zhang; Yanyan Liu
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.